Matched Comparison Between External Aortic Root Support and Valve-sparing Root Replacement
Overview
Authors
Affiliations
Objectives: Differences in indication and technique make a randomised comparison between valve-sparing root replacement (VSRR) and personalised external aortic root support (PEARS) challenging. We performed a propensity score (PS)-matched comparison of PEARS and VSRR for syndromic root aneurysm.
Methods: Patients in the PEARS 200 Database and Aortic Valve Insufficiency and ascending aorta Aneurysm InternATiOnal Registry (undergoing VSRR) with connective tissue disease operated electively for root aneurysm <60 mm with aortic regurgitation (AR) <1/4 were included. Using a PS analysis, 80 patients in each cohort were matched. Survival, freedom from reintervention and from AR ≥2/4 were estimated using a Kaplan-Meier analysis.
Results: Median follow-up was 25 and 55 months for 159 PEARS and 142 VSRR patients. Seven (4.4%) patients undergoing PEARS required an intervention for coronary injury or impingement, resulting in one death (0.6%). After VSRR, there were no early deaths, 10 (7%) reinterventions for bleeding and 1 coronary intervention. Survival for matched cohorts at 5 years was similar (PEARS 98% vs VSRR 99%, p=0.99). There was no difference in freedom from valve or ascending aortic/arch reintervention between matched groups. Freedom from AR ≥2/4 at 5 years in the matched cohorts was 97% for PEARS vs 92% for VSRR (p=0.55). There were no type A dissections.
Conclusions: VSRR and PEARS offer favourable mid-term survival, freedom from reintervention and preservation of valve function. Both treatments deserve their place in the surgical repertoire, depending on a patient's disease stage. This study is limited by its retrospective nature and different follow-ups in both cohorts.
Aortic wall degeneration late after ascending aortic wrapping.
Araki H, Kitamura T, Torii S, Mishima T, Fukuzumi M, Miyaji K Gen Thorac Cardiovasc Surg. 2025; .
PMID: 39988646 DOI: 10.1007/s11748-025-02133-2.
Aortic Valve Repair and Early-Career Surgeons-Nothing Is Impossible.
Djordjevic A, Rudez I J Cardiovasc Dev Dis. 2023; 10(7).
PMID: 37504540 PMC: 10380622. DOI: 10.3390/jcdd10070284.
Marfan Syndrome: Enhanced Diagnostic Tools and Follow-up Management Strategies.
Marelli S, Micaglio E, Taurino J, Salvi P, Rurali E, Perrucci G Diagnostics (Basel). 2023; 13(13).
PMID: 37443678 PMC: 10340634. DOI: 10.3390/diagnostics13132284.